Wells Fargo & Company Green Light Biosciences Holdings, Pbc Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.18 - $0.48 $2,993 - $7,982	-16,630 Reduced 96.33%	634 $0
Q1 2023 May 12, 2023	BUY	$0.34 - $1.19 $5,869 - $20,544	17,264 New	17,264 $7,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $257 - $2,402	613 Added 87.07%	1,317 $3,000
Q2 2022 Aug 12, 2022	BUY	N/A	334 Added 90.27%	704 $2,000
Q1 2022 May 16, 2022	BUY	N/A	370 New	370 $4,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.